Intrinsic Value of S&P & Nasdaq Contact Us

Centene Corporation CNC NYSE

NYSE • Healthcare • Medical - Healthcare Plans • US • USD

SharesGrow Score
55/100
1/7 Pass
SharesGrow Intrinsic Value
$1,904.59
+5013%
Analyst Price Target
$44.90
+20.5%
SharesGrow 7-Criteria Score All 7 criteria scored · income-related highlighted on this page

Centene Corporation (CNC) has shown strong revenue growth over the past 3 years, expanding from $144.5B to $194.8B (average +10.6%/yr). The company reported a net loss of $6.7B in its most recent fiscal year, with earnings trending at -51.6%/yr. The net profit margin is -3.4%, which is negative. the company was profitable in 3 out of the last 4 years tracked. The gross margin is 12.2% (low), with a +0.7pp trend over the period. With a $18B market cap and MOAT composite score of 56/100, the company has a moderate competitive position.

Criteria proven by this page:

  • GROWTH (48/100, Partial) — growth is present but not consistently above 5% across both metrics
  • PAST (75/100, Partial) — profitability has been inconsistent. Looking at the full 27-year history, the company was profitable in 24 of 27 years — a solid long-term record with occasional losses
  • INCOME (10/100, Fail) — the company is currently operating at a loss
  • MOAT (56/100, Partial) — some competitive advantages are present but not dominant

Overall SharesGrow Score: 55/100 with 1/7 criteria passed.

55/100
SG Score
View full scorecard →
VALUE
86/100
Price-to-Earnings & upside
→ IV page
~
FUTURE
58/100
Analyst consensus
→ Forecast
~
PAST
75/100
3/4 yrs profit
EPS –$13.62
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
56/100
Score: 56/100
GM 12.2% (+0.7pp)
Proven by this page
~
GROWTH
48/100
Rev +10.6%/yr
NI -51.6%/yr
Proven by this page
INCOME
10/100
Margin -3.4%
$194.8B
Proven by this page
Centene Corporation Earnings and Revenue History
Analyst Forecast →
Revenue  Actual & Estimate
Earnings & Profit Margin  Actual & Estimate
Metric TTM FY2025 FY2024 FY2023 FY2022
Revenue $194.78B$194.78B$163.07B$154B$144.55B
Gross Profit $28.05B$23.83B$34.64B$31.54B$16.66B
Gross Margin 14.4%12.2%21.2%20.5%11.5%
Operating Income $-7.62B$-7.62B$3.18B$2.93B$3.64B
Net Income $-6.67B$-6.67B$3.31B$2.7B$1.2B
Net Margin -3.4%-3.4%2%1.8%0.8%
EPS (Diluted) $-13.62$-13.62$6.31$4.95$2.07
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message